Company profile ACER

Acer Therapeutics Inc
acer therapeutics is a biotech company, headquartered in cambridge, ma, that develops repurposed and reformulated medicines for the treatment of ultra-orphan diseases with significant unmet medical needs. acer's lead candidate, edviso™ (celiprolol), is the first pharmaceutical therapy seeking approval for patients with vascular-type ehlers-danlos syndrome (veds). ehlers-danlo...s syndrome is a group of hereditary disorders of connective tissue with no ethnic predisposition. veds is a subtype characterized by severe arterial dissections, ruptures and early death. complications are rare in childhood, but affect 25% of patients before the age of 20, and 80% by the age of 40. median age of death is estimated to be around 50 years. patients are diagnosed by clinical symptoms and confirmed by presence of mutations in the col3a1 gene. there are approximately 2,000 documented patients, but prevalence could be as high as 5,000 patients in the u.s. (pepin 2014). there are no specific pharmacologica Show More
Quarter analysis & expected interestLast update: February 08 2024 12:49:54.

After 39 days of this quarter the interest is at 19.0. Based on that we can calculate that during remaining 52 days it will total up to 44.0.
Acer Therapeutics expected interest is significantly lower compared to previous quarter (-61.7%) and same quarter last year (-79.8%).

YearQ1Q2Q3Q4
2019115
226
96.5% QoQ
169
-25.2% QoQ
81
-52.1% QoQ
2020 133
15.7% YoY 64.2% QoQ
191
-15.5% YoY 43.6% QoQ
58
-65.7% YoY -69.6% QoQ
30
-63.0% YoY -48.3% QoQ
2021 286
115.0% YoY 853.3% QoQ
65
-66.0% YoY -77.3% QoQ
137
136.2% YoY 110.8% QoQ
33
10.0% YoY -75.9% QoQ
2022 87
-69.6% YoY 163.6% QoQ
226
247.7% YoY 159.8% QoQ
115
-16.1% YoY -49.1% QoQ
157
375.8% YoY 36.5% QoQ
2023 218
150.6% YoY 38.9% QoQ
129
-42.9% YoY -40.8% QoQ
116
0.9% YoY -10.1% QoQ
115
-26.8% YoY -0.9% QoQ
2024 19
-91.3% YoY -83.5% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Acer Therapeutics search interestLast update: February 08 2024 12:49:50.
Correlation coefficient between keyword and revenue is 0.34
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 12:49:55.

The average 5 years interest of Acer Therapeutics was 10.37 per week.
The last year interest of Acer Therapeutics compared to the last 5 years has changed by -12.44%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -23.83%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Acer Therapeutics EDSIVO to provide analysis

Correlation between past revenue and Acer Therapeutics EDSIVO search interest

There is not enough data for Acer Therapeutics EDSIVO to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Acer Therapeutics EDSIVO to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Acer Therapeutics ACER-801 to provide analysis

Correlation between past revenue and Acer Therapeutics ACER-801 search interest

There is not enough data for Acer Therapeutics ACER-801 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Acer Therapeutics ACER-801 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Acer Therapeutics OLPRUVA to provide analysis

Correlation between past revenue and Acer Therapeutics OLPRUVA search interest

There is not enough data for Acer Therapeutics OLPRUVA to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Acer Therapeutics OLPRUVA to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Acer Therapeutics jobs to provide analysis

Correlation between past revenue and Acer Therapeutics jobs search interest

There is not enough data for Acer Therapeutics jobs to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Acer Therapeutics jobs to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Acer Therapeutics Massachusetts to provide analysis

Correlation between past revenue and Acer Therapeutics Massachusetts search interest

There is not enough data for Acer Therapeutics Massachusetts to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Acer Therapeutics Massachusetts to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Acer Therapeutics near me to provide analysis

Correlation between past revenue and Acer Therapeutics near me search interest

There is not enough data for Acer Therapeutics near me to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Acer Therapeutics near me to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 12:49:59.

After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0.
Acer Therapeutics -stock -company expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).

YearQ1Q2Q3Q4
201916
258
1512.5% QoQ
48
-81.4% QoQ
103
114.6% QoQ
2020 165
931.2% YoY 60.2% QoQ
191
-26.0% YoY 15.8% QoQ
118
145.8% YoY -38.2% QoQ
70
-32.0% YoY -40.7% QoQ
2021 66
-60.0% YoY -5.7% QoQ
88
-53.9% YoY 33.3% QoQ
104
-11.9% YoY 18.2% QoQ
101
44.3% YoY -2.9% QoQ
2022 118
78.8% YoY 16.8% QoQ
229
160.2% YoY 94.1% QoQ
196
88.5% YoY -14.4% QoQ
94
-6.9% YoY -52.0% QoQ
2023 145
22.9% YoY 54.3% QoQ
122
-46.7% YoY -15.9% QoQ
151
-23.0% YoY 23.8% QoQ
94
0.0% YoY -37.7% QoQ
2024 0
-100.0% YoY -100.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Acer Therapeutics -stock -company search interestLast update: February 08 2024 12:49:59.
Correlation coefficient between keyword and revenue is -0.63
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 12:50:02.

The average 5 years interest of Acer Therapeutics -stock -company was 9.49 per week.
The last year interest of Acer Therapeutics -stock -company compared to the last 5 years has changed by -3.9%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by 0.0%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for ACER
Earnings date: 2024-03-25 After close
Company name: Acer Therapeutics Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2025-10-10T05:00:00.000Z

US FDA
Approval of Olpruva, Nda #214860 (Efficacy)

2023-11-30T07:30:25-05:00

SEC
15-12G Form - Securities registration termination [Section 12(g)] - Acer Therapeutics Inc. (0001069308) (Filer)

2023-11-27T00:15:06-05:00

SEC
EFFECT Form - Notice of Effectiveness - Acer Therapeutics Inc. (0001069308) (Filer)

2023-11-27T00:15:05-05:00

SEC
EFFECT Form - Notice of Effectiveness - Acer Therapeutics Inc. (0001069308) (Filer)

2023-11-20T17:09:40-05:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Acer Therapeutics Inc. (0001069308) (Issuer)

2023-11-20T17:07:32-05:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Acer Therapeutics Inc. (0001069308) (Issuer)

2023-11-20T17:05:15-05:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Acer Therapeutics Inc. (0001069308) (Issuer)

2023-11-20T17:03:24-05:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Acer Therapeutics Inc. (0001069308) (Issuer)

2023-11-20T17:03:14-05:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Acer Therapeutics Inc. (0001069308) (Issuer)

2023-11-20T17:01:40-05:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Acer Therapeutics Inc. (0001069308) (Issuer)

2023-11-20T16:51:15-05:00

SEC
10-Q Form - Quarterly report [Sections 13 or 15(d)] - Acer Therapeutics Inc. (0001069308) (Filer)

2023-11-20T16:43:57-05:00

SEC
S-8 POS Form - Securities to be offered to employees in employee benefit plans, post-effective amendments - Acer Therapeutics Inc. (0001069308) (Filer)

2023-11-20T16:42:56-05:00

SEC
S-8 POS Form - Securities to be offered to employees in employee benefit plans, post-effective amendments - Acer Therapeutics Inc. (0001069308) (Filer)

2023-11-20T16:41:57-05:00

SEC
S-8 POS Form - Securities to be offered to employees in employee benefit plans, post-effective amendments - Acer Therapeutics Inc. (0001069308) (Filer)

2023-11-20T16:41:56-05:00

SEC
S-8 POS Form - Securities to be offered to employees in employee benefit plans, post-effective amendments - Acer Therapeutics Inc. (0001069308) (Filer)